COUNCIL FOR SICKLE CELL CHANGE
Live / Applied — Third extension granted (statement of use) (as of 12 Jan 2026)
What this means for you
Not registered yet, but its 21 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98143350
- Mark type
- Stylized text
- Filed
- 21 Aug 2023
- Published for opposition
- 11 Jun 2024
- Attorney of record
- Yana Gorbach
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of sickle cell disease
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2026 — SOU EXTENSION 3 GRANTED
- 12 Jan 2026 — SOU EXTENSION 3 FILED
- 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2025 — SOU EXTENSION 2 GRANTED
- 30 Jun 2025 — SOU EXTENSION 2 FILED
- 30 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2025 — SOU EXTENSION 1 GRANTED
- 06 Jan 2025 — SOU EXTENSION 1 FILED